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Objective/Background: The incidence of resistant strains of Mycobacterium tuberculosis (MTB),
including multi-drug resistant, extensively drug resistant, or totally drug resistant, is one of
the major problems of health policies worldwide. The accumulation of mutations causes
multi-drug resistant strains. Mycobacterium abscessus has a plasmid called pMab2401 con-
taining the trfA1 gene in its integron part. The aim of the present study was to investigate
the possible existence of the trfA1 gene in clinical strains of MTB for the first time.
Methods: Bioinformatics analysis in GenBank revealed an absence of any integrons or inter-
nal components in MTB. Several specific primers for different genes and the trfA1 gene of
M. abscessus were used in a touch-down (60–52) amplification program and followed by
loading on gel electrophoresis. Products were extracted and were sequenced. Sequencing
results were analyzed carefully and compared with those in the databank.
Results: Bands of 500 bp were resulted with pair primers in an amplification reaction by
clinical MTB that has 94% identity with a fragment in most plasmids and phages M13. It
should be noted that such an independent replication system-like structure has not been
reported to date in MTB strains.
Conclusion: The trfA1 gene is depends on the replication process. It is necessary to investi-
gate other probable new areas that may be of concern with drug resistance in clinical iso-
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